DoW Kidney Cancer, Idea Development Award
Defense Health Agency Contracting Activity - DHACA
Program funding
$7,800,000
- Opportunity #
- HT942526KCRPIDA
- Agency
- Defense Health Agency Contracting Activity - DHACA
- ALN (CFDA)
- 12.420
- Status
- posted
- Posted
- Jun 18, 2026
- Closes
- Sep 28, 2026
- Funding instrument
- Grant
- Category
- Science and Technology and other Research and Development
- Cost sharing required
- No
Who can apply
- •Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Synopsis
Summary: The fiscal year 2026 (FY26) Kidney Cancer Research Program (KCRP) Idea Development Award (IDA) supports the development of high-impact ideas that advance the understanding of kidney cancer and ultimately lead to improved patient outcomes. The research project should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach. Personnel on the proposed team should have a strong background in kidney cancer research.
Distinctive Features:
· Partnering Principal Investigator Option: Supports meaningful and productive partnerships between two investigators, termed the Initiating Principal Investigator (PI) and Partnering PI, collaborating on a single application. Only the Initiating PI will submit a pre-application, but all PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
Contact
Jamie Shortall Grant Officer · help@eBRAP.org